Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
D000081:Acetamides / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D004341:Drug Evaluation; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007444:Inulin; D007457:Iodine Radioisotopes; D007483:Iothalamic Acid; D007668:Kidney / Q000503:physiopathology*; D007674:Kidney Diseases / Q000503:physiopathology; D007677:Kidney Function Tests; D007678:Kidney Glomerulus / Q000503:physiopathology; D007684:Kidney Tubules; D009570:Nitriles / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D011339:Probenecid; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000081:Acetamides; D002511:Cephalosporins; D007457:Iodine Radioisotopes; D009570:Nitriles; D007483:Iothalamic Acid; D007444:Inulin; D003404:Creatinine; D011339:Probenecid